PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

We recently compiled a list of 7 Best Russell 2000 Stocks to Buy According to Analysts. In this article, we will look at ...

We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, we are going to take a look ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...

Brands like Kourtney Kardashian's Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

Learn how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients on GLP-1 receptor agonists had a low risk of food retention when an esophagogastroduodenoscopy (EGD ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

A study highlights that GLP-1 RAs are linked to a reduced risk of cirrhosis in patients with MASLD and diabetes. Learn more ...

Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication, Geography, Leading Developers and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.